Benefits of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI) in improving lung function and reducing exacerbations in patients with moderate-to-very severe COPD: a pooled analysis of the PINNACLE studies

BACKGROUND: The Phase III PINNACLE studies assessed the efficacy and safety of glycopyrrolate/formoterol fumarate metered dose inhaler (GFF MDI), a dual long-acting bronchodilator for chronic obstructive pulmonary disease (COPD). Here we present a pre-specified pooled analysis of PINNACLE-1, PINNACL...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Fernando J., Lipworth, Brian J., Rabe, Klaus F., Collier, David J., Ferguson, Gary T., Sethi, Sanjay, Feldman, Gregory J., O’Brien, Gerald, Jenkins, Martin, Reisner, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249639/
https://www.ncbi.nlm.nih.gov/pubmed/32450869
http://dx.doi.org/10.1186/s12931-020-01388-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7249639/
https://www.ncbi.nlm.nih.gov/pubmed/32450869
http://dx.doi.org/10.1186/s12931-020-01388-y

Ejemplares similares